Tamoxifen use increases risk of malignant mixed mullerian tumours

被引:0
|
作者
机构
关键词
Breast Cancer; Relative Risk; Tamoxifen; Invasive Breast Cancer; Absolute Risk;
D O I
10.2165/00128415-200409860-00006
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [42] MALIGNANT MIXED MULLERIAN TUMOR OF UTERINE TUBE
    WU, JP
    TANNER, WS
    FARDAL, PM
    OBSTETRICS AND GYNECOLOGY, 1973, 41 (05): : 707 - 712
  • [43] Multimodal treatment of malignant mixed Mullerian tumor
    Kalincsak Judit
    Gocze Peter
    Bodis Jozsef
    Kovacs Krisztina
    Stefanovits Agnes
    Bohonyi Noemi
    Pentek Sandor
    Papp Szilard
    ORVOSI HETILAP, 2018, 159 (19) : 741 - 747
  • [44] Chemotherapy for malignant mixed mullerian tumors of the ovary
    Sit, ASY
    Price, FV
    Kelley, JL
    Comerci, JT
    Kunschner, AJ
    Kanbour-Shakir, A
    Edwards, RP
    GYNECOLOGIC ONCOLOGY, 2000, 79 (02) : 196 - 200
  • [45] Malignant mixed Mullerian tumor of the urinary bladder
    Schildhaus, H. -U.
    Mikuz, G.
    Fisang, C.
    Steiner, S.
    Buettner, R.
    Wardelmann, E.
    PATHOLOGE, 2008, 29 (05): : 375 - 377
  • [46] Malignant mixed mullerian tumor (MMMT) of the cervix
    Sharma, NK
    Sorosky, JI
    Bender, D
    Fletcher, MS
    Fletcher, MS
    Sood, AK
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 442 - 445
  • [47] Primary malignant mixed mullerian tumor of the vagina
    Neesham, D
    Kerdemelidis, P
    Scurry, J
    GYNECOLOGIC ONCOLOGY, 1998, 70 (02) : 303 - 307
  • [48] Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus
    Horn, L. -C.
    Dallacker, M.
    Bilek, K.
    PATHOLOGE, 2009, 30 (04): : 292 - 301
  • [49] PRIMARY MALIGNANT MIXED MULLERIAN TUMOR OF THE OVARY
    Chiu, Shih-Yun
    Twu, Nae-Fang
    Lai, Chyong-Huey
    Yen, Ming-Shyen
    Chao, Kuan-Chong
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2010, 49 (01): : 87 - 90
  • [50] Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours
    Kosmas, C.
    Vorgias, G.
    Tsakonas, G.
    Politis, P.
    Daladimos, T.
    Panagiotidi, E.
    Papachrysanthou, T.
    Moschovis, D.
    Kalinoglou, N.
    Tsavaris, N.
    Karabelis, A.
    Mylonakis, N.
    BRITISH JOURNAL OF CANCER, 2011, 105 (07) : 897 - 902